Press Releases
AbbVie and Voyager Therapeutics collaborates for Neurodegenerative Diseases
AbbVie , a global biopharmaceutical company, and Voyager Therapeutics, Inc. , a clinical-stage gene therapy company announced that they have entered into an exclusive...
Clinical Trials
AbbVie’s elagolix on a great roll in its PH3 trials
Clinical response was defined as menstrual blood loss volume of less than 80 mL during month six and a 50 percent or greater reduction...
News
Larotrectinib data published in The New England Journal of Medicine: Bayer
Bayer and Loxo Oncology, Inc., , a biopharmaceutical company from Stamford announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib...
Industry Reports
Reckitt Benckiser’s proposal to buy Pfizer makes sense says JP Morgan
Reckitt Benckiser Group PLC is attempting to buy Pfizer Inc’s consumer healthcare business and analysts at JP Morgan think a potential deal makes sense....
Press Releases
Astrazeneca’s Imfinzi for unresectable Stage III non-small cell lung cancer gets FDA approval
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US FDA has approved Imfinzi for the treatment of patients...
Industry Reports
Merck signs its acquisition agreement with Viralytics to Increase its Leading Immuno-Oncolgy Pipeline
Merck , known as MSD outside the USA and Canada, and Viralytics Limited announced that the companies have signed a definitive agreement under which...
News
Envigo appoints Lynn Lewis as Senior Vice President of Global Sales
Envigo, a leading provider of nonclinical contract research services and research models, announced the appointment of Lynn Lewis to the position of Senior Vice...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read